Slide 1: MedCap Company Presentation 2025
ap, ae i MEDCAP INVESTOR IN LIFE SCIENCE Company Presentation 2025
Slide 2: We create value in Life Science and contribute to improved quality of life
We create value in Life Science and contribute to improved quality of life 2
Slide 3: MedCap Snapshot
MedCap Snapshot [2024] Revenue, Business Areas Strategy million SEK Assistive MedTech Specialty Buy & Build Tech Pharma 1 807 A long-term home for well run Life Science companies EBITA margin Employees & locations EBITA CAGR 5 years 17% 556 23% 3
Slide 4: Sales and EBITA rolling 12 months by quarter
Sales and EBITA rolling 12 months by quarter The Group’s net sales LTM (MSEK) The Group’s EBITDA and EBITA (line) LTM (MSEK) excluding one-time effects excluding one-time effects 4
Slide 5: MedCap | An active investor in Life Science companies
MedCap | An active investor in Life Science companies Last Twelve Months, Q4 2024 Sales by Business Area Sales by Market RoW 4% Specialty Pharma Europe 24% 21% Assistive Tech 1 807 42% Sweden MSEK 50% Nordic MedTech 25% 34% 5
Slide 6: Our Model
Our Model Life Science Entrepreneurship Group Scale Sector focus Decentralized & local responsibility Scalable business areas Network of expertise Integrity of acquired brands Merger & Acquisitions Knowledge sharing Quick & agile, yet long-term mindset Governance – ESG Market insight Ambitious organ
Slide 7: Success factors
Success factors Solid markets Understanding the eco-systems Active ownership Non-cyclical Payor Prescriber End-user People & Management Demographic drivers Healthcare providers Distribution Business objectives Market nisches Regulation Sales & Marketing Performance management Market share potential
Slide 8: Examples of healthcare trends relevant to our business
Examples of healthcare trends relevant to our business Assistive Tech MedTech Specialty Pharma Consumer Health Health Economics & Regulations and Requirements Pharmaceutical shortages Screening, Diagnostic Digitalization, Connectivity, Use of data Home care, Telemedicine, Remote Monitoring Prevalenc
Slide 9: MedCap Business Areas
MedCap Business Areas Assistive Tech Med Tech Specialty Pharma Cognition, Alarms, Accessibility Diagnostic ECG Probiotics, Nutrition, Pharma CDMO Communication Packaging Digitalizing work-flow Contract manufacturing Nordic Sales, Pharma Sterile & non-sterile portfolio, Non-license liquid pharma prod
Slide 10: 20 years of scaling businesses through M&A and investments
20 years of scaling businesses through M&A and investments Acquisitions Assistive Tech Med Tech Specialty Pharma 2022 Addera Care 2019 Amajo & KiK Amedtec 2022 2025 2015 Danrehab 2017 2024 New Cognita Miwana Strässle Production Facility 2019 2024 2013 Picomed, Altert-IT 2015 2017 Scandinavian Comai
Slide 11: Investment strategy
Investment strategy Scope What we look for Life Science Assistive | MedTech | Pharma Product / Software / Know-how Value creation journey Europe Clear value proposition Scalable business Add-ons globally M&A possibilities Market fundamentals ESG Innovative PEOPLE Small / Mid-size Businesses Entrepre
Slide 12: Financial Targets
Financial Targets Annual EBITA Growth Return on Equity Net debt / EBITDA Compounded Average Growth Rate >15% >20% <3x 12
Slide 13: Financial Targets
Financial Targets Annual EBITA Growth Return on Equity Net debt / EBITDA Compounded Average Growth Rate [MSEK] >15% >20% <3x 400 3 350 25% 2.5 300 20% 2 250 1.5 15% 200 1 10% 150 0.5 100 5% 0 50 0% 2019 2020 2021 2022 2023 2024 -0.5 0 2019 2020 2021 2022 2023 2024 -1 13
Slide 14: How we track our financial targets in our businesses
How we track our financial targets in our businesses Financial Objectives Key Metrics In Our Businesses Organic and acquisition driven sales growth (depending on maturity of business) >15% EBITA growth (CAGR) Profit margins Core Working Capital / Sales, Cash Conversion, EBITA / (Fixed assets & WC) R
Slide 15: Sales and EBITA rolling 12 months by quarter
Sales and EBITA rolling 12 months by quarter MSEK (Net sales) MSEK (EBITA) 2,00 0 Sales CAGR: 19% 400 1,900 EBITA CAGR: 23% 1,789 1,807 1,800 1,740 1,669 350 1,700 1,587 1,600 328 331 1,5 00 1,4 54 319 300 306 1,4 00 1,331 291 1,3 00 1,229 250 1,200 260 1,111 1,100 1,0 46 1,0 07 23 2 1,0 00 956 200
Slide 16: Why MedCap?
Why MedCap? 1 2 3 4 Sustainable Industry Profitable Growth Proven & Scalable Model Large & Growing Market Life Science industry Annual growth of 19% over Decentralized model – Fragmented market – many improves quality of life the last 5 years customer focused small and medium sized life responsibili
Slide 17: Thank You! Q&A
Thank You ! Q&A Anders Dahlberg Kristina Ekblad CEO CFO anders.dahlberg@medcap.se kristina.ekblad@medcap.se +46 704 269 262 +46 703 322 167 17